Credit Suisse analyst Erin Wright raised her price target for Zoetis to $112 from $102 after meeting with management, that highlighted robust industry fundamentals across both Companion Animal and Livestock markets, as well as the inherent advantages of its diverse portfolio in terms of species, geography, and therapeutic class, with added drivers in innovation and capital deployment. On sustained strength in underlying demand trends and ample topline and profit drivers, the analyst walked away incrementally constructive on the company's near and longer term growth prospects. Wright reiterates an Outperform rating on the shares.